Beam Therapeutics (BEAM) Stock Price, Quote, News & History | Benzinga

Beam Therapeutics Inc (BEAM) Stock Price, Quote, News & History

BEAMNASDAQ

Trade with Public

Trade with Public

$32.68

-3.14-8.77%

At close: Jul 10, 5:00 PM EST

$32.70

0.020.06%

After Hours: Jul 10, 7:45 PM EST

OverviewNews Earnings Events Options Analyst Ratings Insider Trades Short Interest Stock Report

Key Statistics

Open

$35.64

Close

$32.68

Volume / Avg.

2.83M / 2.27M

Day Range

$31.34 - $35.64

52 Wk Range

15.60 - 38.26

Market Cap

$3.36B

P/E Ratio

-

Dividend Yield

-

Exchange

NASDAQ

RSI

48

Short Interest

34.46%

Days to Cover

8.38

Recent Beam Therapeutics Inc News

Prime Medicine Secures Favorable Arbitration Ruling in Beam Therapeutics Case

Prime Medicine won arbitration with Beam Therapeutics over PM647, avoiding damages and keeping its AATD gene-editing program on track.

Vandana Singh

Powder Keg Stocks: 10 Most‑Shorted Names Primed For A Monster Squeeze (CORRECTED)

Data show high levels of short interest in 10 stocks, including Avis Budget, RH, Lucid and CleanSpark.

Erica Kollmann

Jim Cramer: This Tech Stock Is A 'Winner', Snap Does Not Have Growth

Jim Cramer discussed various stocks on Mad Money Lightning Round. He expressed concerns about Ondas Inc's losses and praised companies like Halliburton and Nokia.

Avi Kapoor

Financials

Quarterly

Annual

Name

Revenue Change
Gross Change
EBITDA Change
EBIT Change
Earnings Change

Cash Flows

Operating Cash Flow (TTM)

-369.73M

Investing Cash Flow (TTM)

28.92M

Financing Cash Flow (TTM)

101.28M

Free Cash Flow (TTM)

-383.84M

Capital Expenditure (TTM)

-14.11M

Net Change in Cash (TTM)

-239.53M

Analyst Trends and Forecast

1

Jan

2

Feb

1

Mar

1

May

2

Jul

Buy

Hold

Sell

Strong Sell

Analyst Rating and Forecast

3.5

Hold

Strong Buy

Buy

Hold

Sell

Strong Sell

Valuation Metrics

Enterprise Value

$2.40B

PE Ratio (TTM)

-

PE Ratio (FWD)

-

PEG Ratio (TTM)

-

PS Ratio (TTM)

22.42

PB Ratio (TTM)

3.16

Earnings Yield % (TTM)

-1.37%

Earnings Yield % (FWD)

-13.04%

EV / EBITDA (TTM)

-

Price / EBITDA (TTM)

-

Price / Free Cash Flow (TTM)

-

Book Value / Share

$11.32

Company Debt

Total Debt

$100.19M

LT Debt

$100.19M

LT Debt Issuance (TTM)

-

LT Debt Repayment (TTM)

-

Total Cash

$288.29M

Debt to Equity

0.22

Issuance of Debt (TTM)

$93.89M

Repayment of Debt (TTM)

-

Key Statistics

Open

$35.64

Close

$32.68

Volume / Avg.

2.83M / 2.27M

Day Range

$31.34 - $35.64

52 Wk Range

15.60 - 38.26

Market Cap

$3.36B

P/E Ratio

-

Dividend Yield

-

Exchange

NASDAQ

RSI

48

Short Interest

34.46%

Days to Cover

8.38

About

Sector

Health Care

Industry

Biotechnology

Beam Therapeutics Inc is a biotechnology company committed to creating a new class of precision genetic medicines based on its proprietary base editing technology, with a vision of providing lifelong cures to patients suffering from serious diseases....

Show More

Edge Rankings

Stock Score Locked: Want to See it?

Benzinga Rankings give you vital metrics on any stock – anytime.

Reveal Full Score

Compare

EPS worse than industry

Earnings Per Share

EPS is the portion of a company's profit allocated to each outstanding share of common stock. It is a key metric for investors to assess a company's profitability.

Earnings Per Share

EPS is the portion of a company's profit allocated to each outstanding share of common stock. It is a key metric for investors to assess a company's profitability.

EPS worse than industry

FAQ

Q

How do I buy Beam Therapeutics (BEAM) stock?

A

You can purchase shares of Beam Therapeutics (NASDAQ:BEAM) through any online brokerage.

View our list of the best stock brokerages

Q

Who are Beam Therapeutics (BEAM) competitors?

A

There are no as such competitors for Beam Therapeutics.

Q

What is the forecast, or price target, for Beam Therapeutics (BEAM) stock?

A

Beam Therapeutics has a consensus price target of $49.32.

Q

What is the current price for Beam Therapeutics (BEAM)?

A

The stock price for Beam Therapeutics (NASDAQ: BEAM) is $32.7 last updated July 10, 2026 at 7:45 PM EDT.

Q

Does Beam Therapeutics (BEAM) pay a dividend?

A

There are no upcoming dividends for Beam Therapeutics.

Q

When is Beam Therapeutics (NASDAQ:BEAM) reporting earnings?

A

Beam Therapeutics does not have any upcoming earnings scheduled.

Q

Is Beam Therapeutics (BEAM) going to split?

A

There is no upcoming split for Beam Therapeutics.

Q

What sector and industry does Beam Therapeutics (BEAM) operate in?

A

Beam Therapeutics is in the Health Care sector and Biotechnology industry. They are listed on the NASDAQ.